These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 17409924)

  • 41. Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma.
    Federico R; Adolfo F; Giuseppe M; Lorenzo S; Martino DT; Anna C; Adriano P; Gino C; Francesca R; Matteo C; Gbenga K; Paolo M; Francesco F
    BMC Cancer; 2013 Jan; 13():22. PubMed ID: 23324131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Retreatment of recurrent malignant pleural mesothelioma with cisplatin and pemetrexed.
    Hayashi H; Okamoto I; Ichikawa Y; Miyazaki M; Yoshioka H; Kunimasa K; Nakagawa K
    Int J Clin Oncol; 2010 Oct; 15(5):497-9. PubMed ID: 20224880
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pemetrexed disodium for the treatment of malignant pleural mesothelioma: a systematic review and economic evaluation.
    Dundar Y; Bagust A; Dickson R; Dodd S; Green J; Haycox A; Hill R; McLeod C; Walley T
    Health Technol Assess; 2007 Jan; 11(1):1-90. PubMed ID: 17181984
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pemetrexed combination improves mesothelioma survival.
    Kerr C
    Lancet Oncol; 2005 Aug; 6(8):548. PubMed ID: 16094758
    [No Abstract]   [Full Text] [Related]  

  • 45. Pemetrexed in first-line treatment of non-small cell lung cancer.
    Esteban E; Casillas M; Cassinello A
    Cancer Treat Rev; 2009 Jun; 35(4):364-73. PubMed ID: 19269106
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Second-line chemotherapy in malignant pleural mesothelioma: results of a retrospective multicenter survey.
    Zucali PA; Simonelli M; Michetti G; Tiseo M; Ceresoli GL; Collovà E; Follador A; Lo Dico M; Moretti A; De Vincenzo F; Lorenzi E; Perrino M; Giordano L; Farina G; Santoro A; Garassino M
    Lung Cancer; 2012 Mar; 75(3):360-7. PubMed ID: 21937142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pemetrexed (Alimta, MTA, multitargeted antifolate, LY231514) for malignant pleural mesothelioma.
    Manegold C
    Semin Oncol; 2003 Aug; 30(4 Suppl 10):32-6. PubMed ID: 12917819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carboplatin and pemetrexed in the management of malignant pleural mesothelioma: a realistic treatment option?
    Li L; Razak AR; Hughes A
    Lung Cancer; 2009 May; 64(2):207-10. PubMed ID: 18926592
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy.
    Toyokawa G; Takenoyama M; Hirai F; Toyozawa R; Inamasu E; Kojo M; Morodomi Y; Shiraishi Y; Takenaka T; Yamaguchi M; Shimokawa M; Seto T; Ichinose Y
    Int J Clin Oncol; 2014 Aug; 19(4):601-6. PubMed ID: 24158772
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial.
    Scagliotti GV; Gaafar R; Nowak AK; Nakano T; van Meerbeeck J; Popat S; Vogelzang NJ; Grosso F; Aboelhassan R; Jakopovic M; Ceresoli GL; Taylor P; Orlandi F; Fennell DA; Novello S; Scherpereel A; Kuribayashi K; Cedres S; Sørensen JB; Pavlakis N; Reck M; Velema D; von Wangenheim U; Kim M; Barrueco J; Tsao AS
    Lancet Respir Med; 2019 Jul; 7(7):569-580. PubMed ID: 31103412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program.
    Jänne PA; Wozniak AJ; Belani CP; Keohan ML; Ross HJ; Polikoff JA; Mintzer DM; Taylor L; Ashland J; Ye Z; Monberg MJ; Obasaju CK
    Clin Lung Cancer; 2005 Jul; 7(1):40-6. PubMed ID: 16098243
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [First-line treatment with pemetrexed in association with cisplatin in patients with non-operable malignant pleural mesothelioma].
    Burgin M; Gairard-Dory A-; Mennecier B; Molard A; Beretz L; Quoix A-
    Rev Pneumol Clin; 2009 Apr; 65(2):75-83. PubMed ID: 19375046
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Malignant pleural mesothelioma].
    Nishiwaki Y
    Gan To Kagaku Ryoho; 2003 May; 30(5):589-94. PubMed ID: 12795087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pemetrexed for diffuse malignant pleural mesothelioma.
    Manegold C; Aisner J
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):30-5. PubMed ID: 12023790
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma.
    Jänne PA; Simon GR; Langer CJ; Taub RN; Dowlati A; Fidias P; Monberg M; Obasaju C; Kindler H
    J Clin Oncol; 2008 Mar; 26(9):1465-71. PubMed ID: 18349397
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial.
    Simon GR; Verschraegen CF; Jänne PA; Langer CJ; Dowlati A; Gadgeel SM; Kelly K; Kalemkerian GP; Traynor AM; Peng G; Gill J; Obasaju CK; Kindler HL
    J Clin Oncol; 2008 Jul; 26(21):3567-72. PubMed ID: 18640937
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma.
    Hughes A; Calvert P; Azzabi A; Plummer R; Johnson R; Rusthoven J; Griffin M; Fishwick K; Boddy AV; Verrill M; Calvert H
    J Clin Oncol; 2002 Aug; 20(16):3533-44. PubMed ID: 12177114
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcomes with first-line platinum-based combination chemotherapy for malignant pleural mesothelioma: a review of practice in British Columbia.
    Lee CW; Murray N; Anderson H; Rao SC; Bishop W
    Lung Cancer; 2009 Jun; 64(3):308-13. PubMed ID: 19004520
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.
    Krug LM; Pass HI; Rusch VW; Kindler HL; Sugarbaker DJ; Rosenzweig KE; Flores R; Friedberg JS; Pisters K; Monberg M; Obasaju CK; Vogelzang NJ
    J Clin Oncol; 2009 Jun; 27(18):3007-13. PubMed ID: 19364962
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study.
    Buikhuisen WA; Burgers JA; Vincent AD; Korse CM; van Klaveren RJ; Schramel FM; Pavlakis N; Nowak AK; Custers FL; Schouwink JH; Gans SJ; Groen HJ; Strankinga WF; Baas P
    Lancet Oncol; 2013 May; 14(6):543-51. PubMed ID: 23583604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.